Dr. Jack D. Schim, M.D
Neurology (Neurology Physician)
6010 Hidden Valley Rd Ste 200
Carlsbad, CA 92011
Who else practices at this address →
San Diego County includes primary care (1% of residents) and mental health (1% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of California, San Diego School of Medicine (1981)
- Years since graduation
- 45
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 425
Licensed in California since 1982, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1981Medical school: University of California, San Diego School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
CA license G48807 (first issued 1982; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- UC San Diego Health Hillcrest - Hillcrest Med Ctr San Diego, CA
Medical groups
- North County Neurology Associates Medical Group (47 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 425
- Services billed
- 207,536
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 211,665 | 322 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 652 | 236 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 245 | 88 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 168 | 20 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 149 | 49 |
| Established patient office or other outpatient visit, 30-39 minutes | 125 | 106 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | 84 | 31 |
| Injection, ketorolac tromethamine, per 15 mg | 80 | 27 |
| Injection of chemical for paralysis of nerve muscles on side of face | 61 | 23 |
| Established patient office or other outpatient visit, 40-54 minutes | 57 | 53 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Sumatriptan Succinate Other prescribers in Carlsbad, CA | 240 |
| Naratriptan Hcl | 124 |
| Botox (onabotulinumtoxina) | 103 |
| Nurtec Odt (rimegepant sulfate) Other prescribers in Carlsbad, CA | 100 |
| Aimovig Autoinjector (erenumab-aooe) Other prescribers in Carlsbad, CA | 95 |
| Emgality Pen (galcanezumab-gnlm) Other prescribers in Carlsbad, CA | 84 |
| Rizatriptan (rizatriptan benzoate) Other prescribers in Carlsbad, CA | 83 |
| Topiramate Other prescribers in Carlsbad, CA | 73 |
| Ubrelvy (ubrogepant) Other prescribers in Carlsbad, CA | 72 |
| Gabapentin Other prescribers in Carlsbad, CA | 63 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 118 payments worth $125,883 in total to this clinician.
| Ipsen Innovation | $44,442 |
|---|---|
| Axsome Therapeutics, Inc. | $43,551 |
| AbbVie Inc. | $20,297 |
| Pfizer Inc. | $8,830 |
| Lundbeck LLC | $8,518 |
| Tonix Medicines, Inc. | $63.53 |
| Teva Pharmaceuticals USA, Inc. | $41.35 |
| UCB, Inc. | $29.84 |
| Consulting Fee | $46,778 |
|---|---|
| Honoraria | $44,526 |
| Compensation for services other than consulting (speaking, faculty) | $22,875 |
| Travel and Lodging | $8,335 |
| Food and Beverage | $3,370 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Ipsen Innovation Oct 10, 2025 | Consulting Fee | $23,430 |
| Axsome Therapeutics, Inc. Jul 17, 2025 | Honoraria Symbravo · Neurology | $12,325 |
| Axsome Therapeutics, Inc. Nov 5, 2025 | Honoraria Symbravo · Neurology | $10,875 |
| Ipsen Innovation Aug 15, 2025 | Consulting Fee | $10,650 |
| Ipsen Innovation Oct 24, 2025 | Consulting Fee | $8,760 |
| Axsome Therapeutics, Inc. Dec 10, 2025 | Honoraria Symbravo · Neurology | $4,713 |
| AbbVie Inc. Dec 18, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $4,550 |
| Axsome Therapeutics, Inc. Aug 7, 2025 | Honoraria Symbravo · Neurology | $3,263 |
| AbbVie Inc. Jul 10, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $3,250 |
| AbbVie Inc. Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) UBRELVY · NEUROSCIENCE | $3,250 |
All 49 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Lundbeck LLC Dec 22, 2025 | Honoraria VYEPTI · NEUROLOGY | $2,100 |
| AbbVie Inc. Dec 18, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $4,550 |
| Pfizer Inc. Dec 18, 2025 | Compensation for services other than consulting (speaking, faculty) NURTEC ODT · PAIN | $3,150 |
| Axsome Therapeutics, Inc. Dec 10, 2025 | Honoraria Symbravo · Neurology | $4,713 |
| Axsome Therapeutics, Inc. Dec 10, 2025 | Honoraria Symbravo · Neurology | $1,450 |
| Axsome Therapeutics, Inc. Dec 10, 2025 | Travel and Lodging Symbravo · Neurology · travel to Temple City, CA · in-kind | $1,090 |
| AbbVie Inc. Dec 6, 2025 | Travel and Lodging QULIPTA · NEUROSCIENCE · travel to SCOTTSDALE, AZ · in-kind | $173 |
| AbbVie Inc. Dec 4, 2025 | Travel and Lodging QULIPTA · NEUROSCIENCE · travel to SCOTTSDALE, AZ · in-kind | $423 |
| AbbVie Inc. Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) UBRELVY · NEUROSCIENCE | $3,250 |
| AbbVie Inc. Nov 10, 2025 | Consulting Fee | $975 |
| Pfizer Inc. Nov 7, 2025 | Travel and Lodging NURTEC ODT · PAIN · travel to Temecula, CA · in-kind | $715 |
| Lundbeck LLC Nov 6, 2025 | Honoraria VYEPTI · NEUROLOGY | $2,100 |
| Axsome Therapeutics, Inc. Nov 5, 2025 | Honoraria Symbravo · Neurology | $10,875 |
| Pfizer Inc. Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) NURTEC ODT · PAIN | $3,150 |
| Ipsen Innovation Oct 24, 2025 | Consulting Fee | $8,760 |
| AbbVie Inc. Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $1,463 |
| Axsome Therapeutics, Inc. Oct 22, 2025 | Honoraria Symbravo · Neurology | $1,450 |
| AbbVie Inc. Oct 19, 2025 | Travel and Lodging BOTOX · BOTOX THERAPEUTIC · travel to SHREWSBURY, NJ · in-kind | $658 |
| Axsome Therapeutics, Inc. Oct 16, 2025 | Travel and Lodging Symbravo · Neurology · travel to Newark, NJ · in-kind | $1,039 |
| Axsome Therapeutics, Inc. Oct 16, 2025 | Travel and Lodging Symbravo · Neurology · travel to Parsippany, NJ · in-kind | $737 |
| Axsome Therapeutics, Inc. Oct 16, 2025 | Travel and Lodging Symbravo · Neurology · travel to Parsippany, NJ · in-kind | $322 |
| Axsome Therapeutics, Inc. Oct 16, 2025 | Travel and Lodging Symbravo · Neurology · travel to Parsippany, NJ · in-kind | $299 |
| Axsome Therapeutics, Inc. Oct 16, 2025 | Travel and Lodging Symbravo · Neurology · travel to Fairfield, NJ · in-kind | $299 |
| Axsome Therapeutics, Inc. Oct 16, 2025 | Travel and Lodging Symbravo · Neurology · travel to San Diego, CA | $140 |
| Pfizer Inc. Oct 15, 2025 | Consulting Fee NURTEC ODT · PAIN | $1,525 |
| Lundbeck LLC Oct 15, 2025 | Consulting Fee VYEPTI · NEUROLOGY | $788 |
| Ipsen Innovation Oct 10, 2025 | Consulting Fee | $23,430 |
| AbbVie Inc. Oct 9, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $975 |
| Axsome Therapeutics, Inc. Oct 1, 2025 | Honoraria Symbravo · Neurology | $1,450 |
| Axsome Therapeutics, Inc. Aug 22, 2025 | Honoraria Symbravo · Neurology | $1,450 |
| Ipsen Innovation Aug 15, 2025 | Consulting Fee | $10,650 |
| Axsome Therapeutics, Inc. Aug 7, 2025 | Honoraria Symbravo · Neurology | $3,263 |
| Axsome Therapeutics, Inc. Aug 7, 2025 | Travel and Lodging Symbravo · Neurology · travel to Encinitas, CA | $11.20 |
| Axsome Therapeutics, Inc. Aug 7, 2025 | Travel and Lodging Symbravo · Neurology · travel to Encinitas, CA | $10.00 |
| Axsome Therapeutics, Inc. Jul 17, 2025 | Honoraria Symbravo · Neurology | $12,325 |
| AbbVie Inc. Jul 10, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $3,250 |
| Axsome Therapeutics, Inc. Jun 26, 2025 | Travel and Lodging Symbravo · Neurology · travel to Dallas, TX | $209 |
| AbbVie Inc. Jun 26, 2025 | Travel and Lodging BOTOX · NEUROSCIENCE · travel to SAN DIEGO, CA · in-kind | $28.00 |
| AbbVie Inc. Jun 26, 2025 | Travel and Lodging BOTOX · NEUROSCIENCE · travel to SAN DIEGO, CA · in-kind | $3.00 |
| Ipsen Innovation Jun 18, 2025 | Travel and Lodging travel to Minneapolis, MN · in-kind | $824 |
| Ipsen Innovation Jun 17, 2025 | Travel and Lodging travel to Minneapolis, MN · in-kind | $472 |
| Axsome Therapeutics, Inc. Jun 7, 2025 | Travel and Lodging Symbravo · Neurology · travel to Dallas-Fort Worth, TX · in-kind | $652 |
| Axsome Therapeutics, Inc. Jun 7, 2025 | Travel and Lodging Symbravo · Neurology · travel to Dallas, TX · in-kind | $198 |
| Axsome Therapeutics, Inc. Jun 7, 2025 | Travel and Lodging Symbravo · Neurology · travel to Dallas, TX · in-kind | $33.48 |
| AbbVie Inc. May 12, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $1,625 |
| AbbVie Inc. May 12, 2025 | Compensation for services other than consulting (speaking, faculty) BOTOX · NEUROSCIENCE | $1,463 |
| Lundbeck LLC Apr 8, 2025 | Honoraria VYEPTI · NEUROLOGY | $2,100 |
| Lundbeck LLC Mar 18, 2025 | Honoraria VYEPTI · NEUROLOGY | $1,250 |
| AbbVie Inc. Feb 19, 2025 | Consulting Fee UBRELVY · NEUROSCIENCE | $650 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $130,510 in research payments for these studies, mostly to the institutions running them.
- A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
H. Lundbeck A S · Completed · NCT06323928 - A phase 2,randomised,multicentre, parallel group treatment,double blind study to investigate the safety and efficacy of subcutaneous MEDI0618 in the reduction of migraine headache days compared to placebo in adult par…
AstraZeneca UK Limited - A Phase 2, Randomised, Multicentre, Parallel-Group Treatment, Double-Blind Study to Investigate the Safety and Efficacy of Subcutaneous MEDI0618 in the Reduction of Migraine Headache Days Compared to Placebo in Adult …
AbbVie Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.